August 1, 2018 Comments Off on Ten years of biosimilars in Europe: development and evolution of the regulatory pathways Posted in: Insights This paper was originally published by Martin Schiestl, Markus Zabransky, and Fritz Sörgel in Drug Des Devel Ther. 2017; 11: 1509–1515 under a Creative Commons Attribution – Non Commercial (unported, v3.0) License. Abstract…
The post Ten years of biosi…
July 31, 2018 Comments Off on Make better decisions with advanced biopharmaceutical business intelligence Posted in: Featured, Insights What can we build for you? Do you have special business intelligence needs? Let us apply our industry expertise and the strength of the DrugPatentWatch platform to develop a solution…
The post Make better decisions with advanced biopharmaceutical busin…